Clinical trial

A Study for Japanese Participants With Rheumatoid Arthritis (RA)

NCT01253226

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-09-01

PhasePHASE1

Study timeline

Study start (unknown)2009-09-01Date precision: month

Registry last updated2018-10-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

LY2127399 (Tabalumab)DRUG

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

TokyoJapan1 OsakaJapan1 ChibaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01253226 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.